Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus | PNAS
Harnessing the metabolic potential of Streptococcus thermophilus for new biotechnological applications - ScienceDirect
WO2015089465A1 - Delivery, use and therapeutic applications of the crispr-cas systems and compositions for hbv and viral diseases and disorders - Google Patents
Epigenetic Segregation of Microbial Genomes from Complex Samples Using Restriction Endonucleases HpaII and McrB | PLOS ONE
Epigenetic Segregation of Microbial Genomes from Complex Samples Using Restriction Endonucleases HpaII and McrB | PLOS ONE
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research | ACS Synthetic Biology
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus | PNAS
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
Humankind 2.0: The Technologies of the Future 6. Biotech
Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA | Nature Communications
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research | ACS Synthetic Biology
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors
Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo | Nature Communications
Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13 | ACS Synthetic Biology
WO2016205764A9 - Novel crispr enzymes and systems - Google Patents
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13 | ACS Synthetic Biology
Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA | Nature Communications
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
How Crispr went from niche to Nobel | Feature | Chemistry World
Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA | Nature Communications
